Clinical Trial Update: Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronic acid with vitamin D and calcium, with or without radiopharmaceuticals strontium-89 or samarium-153, to prevent or delay bone…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Prostate Cancer

Drugs mentioned

• Calcium carbonate (Calcium carbonate)
• Samarium-153 (samarium-153)
• Strontium-89 (strontium-89)
• Vitamin D3 (Cholecalciferol)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Breast Cancer, Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-11-10